Evaluate, a Norstella company, announces acquisition of J+D Forecasting

J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry, is excited to officially share the news of our acquisition by Evaluate, a distinguished member of the Norstella family.

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

A single-dose intranasal vaccine effectively induces robust immune responses.

October 24, 2023

Expanding access to GLP-1 weight-loss drugs could save thousands of lives

Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates and addressing health inequities. Current drug uptake levels

October 17, 2024

Dietary experts advise skipping guidelines on ultra-processed foods — for now

If you were hoping to see where ultra-processed foods might fit in the next Dietary Guidelines for Americans, hold that thought. Scientific experts tasked with

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.